| ￥5800 | |
| Z04484-100 | |
|
|
|
|
|
|
|
|
|
| Species | Human | ||||||
| Protein Construction |
|
||||||
| Conjugate | Biotin | ||||||
| Purity | > 95% as determined by BisTris PAGE | ||||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||||
| Biological Activity | Measured by its binding ability in a functional ELISA.Test result was comparable to standard batch. | ||||||
| Expression System | HEK293 | ||||||
| Theoretical Molecular Weight | 105.8 kDa (alpha subunit) and 23 kDa (beta subunit) | ||||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 110-120 kDa (alpha subunit) and 52-55 kDa (beta subunit) based on Bis-Tris PAGE result. | ||||||
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). | ||||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||||
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
Immobilized IGF1R/CD221[Biotin], His & Avi, Human, His Tag at 5 μg/ml (100 μl/Well) on streptavidin(5 μg/ml) precoated plate. Dose response curve for Human IGFI, hFc Tag with the EC50 of 0.79 μg/ml determined by ELISA. »
The purity of IGF1R/CD221[Biotin], His & Avi, Human is greater than 95% as determined by SEC-HPLC. »
IGF1R/CD221[Biotin], His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
Immobilized IGF1R/CD221[Biotin], His & Avi, Human, His Tag at 5 μg/ml(100 μl/well) on the plate. Dose response curve for Human IGFI, hFc Tag with the EC50 of 0.83 ng/ml determined by ELISA. »
Immobilized IGF1R/CD221[Biotin], His & Avi, Human, His Tag at 0.2 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-IGF1R Antibody, hFc Tag with the EC50 of 12.6ng/ml determined by ELISA. »
| Target Background | The type 1 IGF receptor (IGF1R) is a transmembrane tyrosine kinase that is frequently overexpressed by tumours, and mediates proliferation and apoptosis protection. IGF signalling also influences hypoxia signalling, protease secretion, tumour cell motility and adhesion, and thus can affect the propensity for invasion and metastasis. Therefore, the IGF1R is now an attractive anti-cancer treatment target. |
| Synonyms | CD221; IGF1R; IGF-1R; IGF-I R; IGF-I receptor; IGFIR; IGFR; JTK13; MGC142170; MGC142172; MGC18216 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
